Literature DB >> 15983790

Processing efficiency of a verbal working memory system is modulated by amphetamine: an fMRI investigation.

Christine M Tipper1, Tara A Cairo, Todd S Woodward, Anthony G Phillips, Peter F Liddle, Elton T C Ngan.   

Abstract

RATIONALE: Working memory performance may be improved or decreased by amphetamine, depending on baseline working memory capacity and amphetamine dosage. This variable effect suggests an optimal range of monaminergic activity for working memory, either below or above which it is compromised. We directly tested this possibility with human participants by varying amphetamine dosage and measuring the efficiency of cortical processing in brain regions associated with working memory.
OBJECTIVES: The modulation of cortical processing in a verbal working memory network by dextroamphetamine (D-amph) was examined using BOLD functional magnetic resonance imaging (fMRI) with healthy participants. The goal of the study was to test the hypothesis of an inverted U-shaped relationship between D-amph dose and processing efficiency of a verbal working memory system.
METHODS: D-amph dosage was increased cumulatively every 2 h across four scanning sessions collected in a single day. The primary measure used for analyses in this study was the extent of activation in brain regions empirically defined as a working memory network.
RESULTS: An inverted U-shaped relationship was observed between the amount of D-amph administered and working memory processing efficiency. This relationship was specific to brain areas functionally defined as working memory regions and to the encoding/maintenance phase (as opposed to the response phase) of the task.
CONCLUSION: The results are consistent with the hypothesis that the neurochemical effects of amphetamine modulate the efficiency of a verbal working memory system. The effect of amphetamine on working memory in healthy individuals may provide insight regarding the working memory deficits seen in schizophrenia, given the overlap between neurochemical systems affected by amphetamine, and those disordered in schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15983790     DOI: 10.1007/s00213-005-0025-4

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  49 in total

1.  Distinct contributions of glutamate and dopamine receptors to temporal aspects of rodent working memory using a clinically relevant task.

Authors:  J M Aultman; B Moghaddam
Journal:  Psychopharmacology (Berl)       Date:  2001-01       Impact factor: 4.530

2.  D1 dopamine receptors in prefrontal cortex: involvement in working memory.

Authors:  T Sawaguchi; P S Goldman-Rakic
Journal:  Science       Date:  1991-02-22       Impact factor: 47.728

3.  Self-monitoring cognitive performance during sleep deprivation: effects of modafinil, d-amphetamine and placebo.

Authors:  J V Baranski; R A Pigeau
Journal:  J Sleep Res       Date:  1997-06       Impact factor: 3.981

4.  Glutamatergic and dopaminergic afferents to the prefrontal cortex regulate spatial working memory in rats.

Authors:  A J Romanides; P Duffy; P W Kalivas
Journal:  Neuroscience       Date:  1999       Impact factor: 3.590

5.  Modulation of memory fields by dopamine D1 receptors in prefrontal cortex.

Authors:  G V Williams; P S Goldman-Rakic
Journal:  Nature       Date:  1995-08-17       Impact factor: 49.962

Review 6.  Working memory dysfunction in schizophrenia.

Authors:  P S Goldman-Rakic
Journal:  J Neuropsychiatry Clin Neurosci       Date:  1994       Impact factor: 2.198

7.  Catecholamine modulation of prefrontal cortical cognitive function.

Authors:  A F Arnsten
Journal:  Trends Cogn Sci       Date:  1998-11-01       Impact factor: 20.229

8.  Working memory dysfunction in major depression: an event-related potential study.

Authors:  L Pelosi; T Slade; L D Blumhardt; V K Sharma
Journal:  Clin Neurophysiol       Date:  2000-09       Impact factor: 3.708

9.  Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia.

Authors:  M F Egan; T E Goldberg; B S Kolachana; J H Callicott; C M Mazzanti; R E Straub; D Goldman; D R Weinberger
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-29       Impact factor: 11.205

10.  Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine.

Authors:  Venkata S Mattay; Terry E Goldberg; Francesco Fera; Ahmad R Hariri; Alessandro Tessitore; Michael F Egan; Bhaskar Kolachana; Joseph H Callicott; Daniel R Weinberger
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-25       Impact factor: 11.205

View more
  12 in total

1.  Amphetamine Exerts Dose-Dependent Changes in Prefrontal Cortex Attractor Dynamics during Working Memory.

Authors:  Christopher C Lapish; Emili Balaguer-Ballester; Jeremy K Seamans; Anthony G Phillips; Daniel Durstewitz
Journal:  J Neurosci       Date:  2015-07-15       Impact factor: 6.167

2.  C957T polymorphism of the dopamine D2 receptor gene modulates the effect of nicotine on working memory performance and cortical processing efficiency.

Authors:  Leslie K Jacobsen; Kenneth R Pugh; W Einar Mencl; Joel Gelernter
Journal:  Psychopharmacology (Berl)       Date:  2006-08-09       Impact factor: 4.530

Review 3.  Are prescription stimulants "smart pills"? The epidemiology and cognitive neuroscience of prescription stimulant use by normal healthy individuals.

Authors:  M Elizabeth Smith; Martha J Farah
Journal:  Psychol Bull       Date:  2011-09       Impact factor: 17.737

4.  Nondependent stimulant users of cocaine and prescription amphetamines show verbal learning and memory deficits.

Authors:  Martina Reske; Carolyn A Eidt; Dean C Delis; Martin P Paulus
Journal:  Biol Psychiatry       Date:  2010-06-03       Impact factor: 13.382

5.  Pre-encoding administration of amphetamine or THC preferentially modulates emotional memory in humans.

Authors:  Michael E Ballard; David A Gallo; Harriet de Wit
Journal:  Psychopharmacology (Berl)       Date:  2012-12-09       Impact factor: 4.530

6.  Sleep deprivation decreases binding of [11C]raclopride to dopamine D2/D3 receptors in the human brain.

Authors:  Nora D Volkow; Gene-Jack Wang; Frank Telang; Joanna S Fowler; Jean Logan; Christopher Wong; Jim Ma; Kith Pradhan; Dardo Tomasi; Peter K Thanos; Sergi Ferré; Millard Jayne
Journal:  J Neurosci       Date:  2008-08-20       Impact factor: 6.167

7.  An fMRI study of prefrontal brain activation during multiple tasks in patients with major depressive disorder.

Authors:  Paul B Fitzgerald; Anusha Srithiran; Jessica Benitez; Zafiris Z Daskalakis; Tom J Oxley; Jayashri Kulkarni; Gary F Egan
Journal:  Hum Brain Mapp       Date:  2008-04       Impact factor: 5.038

8.  Amphetamine increases errors during episodic memory retrieval.

Authors:  Michael Edward Ballard; David A Gallo; Harriet de Wit
Journal:  J Clin Psychopharmacol       Date:  2014-02       Impact factor: 3.153

9.  Differential effects of the D- and L- isomers of amphetamine on pharmacological MRI BOLD contrast in the rat.

Authors:  Neil Easton; Fiona Marshall; Kevin C F Fone; Charles A Marsden
Journal:  Psychopharmacology (Berl)       Date:  2007-03-27       Impact factor: 4.415

10.  A positron emission tomography study of nigro-striatal dopaminergic mechanisms underlying attention: implications for ADHD and its treatment.

Authors:  Natalia del Campo; Tim D Fryer; Young T Hong; Rob Smith; Laurent Brichard; Julio Acosta-Cabronero; Samuel R Chamberlain; Roger Tait; David Izquierdo; Ralf Regenthal; Jonathan Dowson; John Suckling; Jean-Claude Baron; Franklin I Aigbirhio; Trevor W Robbins; Barbara J Sahakian; Ulrich Müller
Journal:  Brain       Date:  2013-11       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.